We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic-Assisted Surgery Found Superior in Gynecologic Oncology

By HospiMedica International staff writers
Posted on 30 Dec 2008
A new study has found that found that robotic radical hysterectomy (RRH) results in lower blood loss and shorter length of stay compared with traditional open radical hysterectomies (ORH) in patients with stage I and II cervical cancer.

Researchers from Brigham and Women's Hospital (BWH, Boston, MA, USA) reviewed and compared intraoperative and postsurgical factors for 16 RRH (using the DaVinci robot) and 32 ORH procedures performed between August 2004 and June 2007. More...
Demographic data, operative data, and short-term outcomes were compared; the groups did not differ significantly in age, body mass index (BMI), stage, or histology.

The researchers found that although the surgeries took longer, patients who underwent RRH had less blood loss compared with those who had ORH procedures. Patients who had an RRH also had shorter hospital stays after the surgery compared with patients who had ORH. There were no intraoperative complications in the RRH group and one ureteral transection in the ORH group. Three RRH patients (18.8%) suffered postoperative complications which included a vaginal cuff infected hematoma, a transient ureterovaginal fistula, and a pelvic lymphocele, in comparison to seven in the ORH group (21.9%) which included three wound infections, two patients with pulmonary emboli, a partial small bowel obstruction with a mesenteric abscess, and a postoperative ileus. The mean number of lymph nodes resected did not differ between RRHs and ORHs. The study was published in the December 2008 issue of the journal Gynecologic Oncology.

"Robotic radical hysterectomy is a new and important method for both surgeons and patients as the entire field of surgery trends toward minimally invasive procedures. In our study, we show that this approach can reduce both blood loss and the length of hospital stay for the patient,” said senior author Colleen Feltmate, M.D., a gynecologic oncology surgeon at BWH.

Robotic-assisted surgery offers many advantages for the surgeon: True three-dimensional (3D) high magnification vision, greatly lowered blood loss, and normal "intuitive” manipulation of surgical instruments. The technology translates a surgeon's hand movements exactly as he/she does them, but also allows the surgeon to scale their hand movements; a large hand movement at the console can be translated into a micro-precise dissection or exposure. The robot can also filter out hand tremors, enhancing precision.

Related Links:
Brigham and Women's Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.